Thyroid Removal: Consequences, Rehabilitation, and Treatment Alternatives

Thyroid Removal: When Is It Necessary?

Thyroidectomy, or surgical removal of the thyroid gland, is one of the most common endocrine surgeries. It is a serious intervention resorted to in various pathologies when conservative treatment is ineffective or impossible. The main indications for thyroidectomy are:

• Thyroid cancer: in most cases, it is an absolute indication for total or partial removal of the gland.
• Benign nodules and goiter: when there is a significant increase in size causing compression of the trachea or esophagus, as well as when malignancy is suspected.
• Hyperthyroidism (thyrotoxicosis): especially in Graves' disease, when drug treatment yields no results, side effects from medications occur, or there are contraindications to radioactive iodine therapy.

The choice of the extent of surgery (complete removal—total thyroidectomy, or partial—hemithyroidectomy) depends on the diagnosis, size, and nature of the gland lesion, as well as the individual characteristics of the patient.

Alternatives to Surgical Intervention in Graves' Disease

In Graves' disease, which is a frequent cause of hyperthyroidism, surgical removal of the thyroid gland is not the only treatment option. There are other approaches that can be considered depending on the clinical picture and patient preferences.

One such method is ultrasound-guided thermal ablation (UGTA), which includes radiofrequency ablation (RFA) and microwave ablation (MWA). These minimally invasive techniques are offered as an alternative to surgery or radioactive iodine therapy for patients with Graves' disease who do not respond to antithyroid drugs. A systematic review and meta-analysis showed that after UGTA, only about 2.4% of patients required levothyroxine replacement therapy after one year, indicating the preservation of thyroid function in the majority [4]. This significantly distinguishes this method from total thyroidectomy, after which replacement therapy is required for life.

Another important alternative is radioactive iodine therapy (RAIT). The effectiveness of RAIT may depend on the duration of prior antithyroid drug (ATD) use. A study showed that a shorter course of ATDs before RAIT was associated with better outcomes, such as a significant reduction in thyroid weight and a greater percentage reduction in its volume one year after treatment compared to long-term ATD use [8]. This emphasizes the importance of an individualized approach to RAIT preparation.

The choice of treatment method (surgery, ablation, RAIT) depends on many factors, including the size of the goiter, the degree of hyperthyroidism, the presence of ophthalmopathy, the patient's age, comorbid conditions, and personal preferences.

Immediate Postoperative Period and Recovery

Following a thyroidectomy, as after any surgical intervention, there is a recovery period. Although studies often focus on specific operations, such as intracranial electrode implantation for epilepsy [7], the general principles of postoperative recovery also apply to thyroidectomy, albeit with consideration of its specifics.

Important indicators of postoperative recovery include time to adequate oral intake, the amount of analgesics and antiemetics administered, time to removal of the urinary catheter, normalization of body temperature, and blood parameters (such as white blood cells and C-reactive protein) [7]. After thyroidectomy, patients usually stay in the hospital for 1-2 days. During this period, medical staff closely monitor the patient's condition, checking:

• Pain: usually moderate, well-managed with standard analgesics.
• Voice: temporary hoarseness or a change in voice pitch is possible due to edema or irritation of the recurrent laryngeal nerve. In rare cases, more permanent nerve damage may occur.
• Calcium levels: monitoring blood calcium levels is extremely critical due to the risk of damage or temporary dysfunction of the parathyroid glands located near the thyroid gland. This can lead to hypocalcemia, manifesting as numbness, tingling in the extremities, or cramps.
• Bleeding and swelling: rare but possible complications requiring immediate attention.

Patients are advised to avoid sudden head and neck movements in the first days after surgery and to observe vocal rest if necessary.

Long-Term Consequences: Hormone Replacement Therapy

One of the most significant long-term consequences of total thyroidectomy is the lifelong need for hormone replacement therapy. After complete removal of the thyroid gland, the body stops producing thyroid hormones, which play a key role in regulating metabolism, energy, and many other bodily functions.

Unlike thermal ablation, where thyroid function can be preserved in the majority of patients (only 2.4% needed levothyroxine after ablation according to one review [4]), replacement therapy becomes mandatory after complete thyroid removal. Patients are prescribed the synthetic hormone thyroxine (levothyroxine), which completely replaces natural hormones. A properly selected dose allows maintaining normal metabolism and quality of life while preventing the development of hypothyroidism.

Regular monitoring of blood thyroid-stimulating hormone (TSH) levels is necessary for the precise adjustment of the levothyroxine dosage. Target TSH values may vary depending on the reason for the surgery (for example, in thyroid cancer, the target TSH may be lower).

Rehabilitation and Quality of Life After Surgery

Rehabilitation after thyroidectomy includes not only physical recovery but also adaptation to new living conditions with replacement therapy. The goal of rehabilitation is the fastest possible return to a full life and maintenance of a high quality of life.

• Physical rehabilitation:
  
  • Neck exercises: to prevent stiffness and restore full range of motion. They should be started cautiously, following a doctor's recommendation.
  • Scar management: after the suture heals, scar massage, special creams, or silicone patches may be recommended to minimize its visibility.
  • Voice restoration: in the presence of hoarseness, consultations with a phoniatrist and special exercises can be useful.
  • Gradual return to normal activity: most patients can return to light work and daily chores in 1-2 weeks, and to full physical activity in 4-6 weeks.
• Psychological adaptation:
  
  • Understanding the need for lifelong medication intake and regular monitoring.
  • Support from family, friends, and medical professionals plays an important role.
  • Rare, but possible changes in mood or energy levels associated with fluctuations in hormone levels before dose stabilization require attention and correction.

The quality of life of most patients after successful thyroidectomy and adequate replacement therapy remains high. It is important to remember that timely diagnosis and proper treatment allow many complications to be avoided.

Monitoring and Further Management

Regular medical monitoring is necessary after thyroidectomy and is key to maintaining health and preventing potential complications. This is especially important for patients who underwent surgery for thyroid cancer.

• Regular blood tests: for thyroid-stimulating hormone (TSH) and free thyroid hormone fractions (T4, T3) to monitor the adequacy of replacement therapy.
• Neck ultrasound: especially in thyroid cancer, to monitor for possible disease recurrence or the appearance of metastases in the lymph nodes. The frequency of ultrasound is determined by the attending physician.
• Endocrinologist consultations: regular visits to a specialist to assess overall condition, adjust drug dosages, and discuss any emerging questions.
• Calcium level control: in the presence of hypoparathyroidism after surgery, lifelong intake of calcium and vitamin D supplements with regular level monitoring is required.

Compliance with medical recommendations and regular intake of levothyroxine are key to preventing complications and maintaining health throughout life.

Sources

• 1. Oxaliplatin-induced rhabdomyolysis in a postoperative rectal cancer patient: a case report and literature review. https://pubmed.ncbi.nlm.nih.gov/42712673/
• 2. Ocrelizumab discontinuation in multiple sclerosis: relapse of disease activity. https://pubmed.ncbi.nlm.nih.gov/41558853/
• 3. Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis. https://pubmed.ncbi.nlm.nih.gov/42496160/
• 4. Ultrasound-guided thermal ablation in patients with Graves' disease: a systematic review and meta-analysis. https://pubmed.ncbi.nlm.nih.gov/42570056/
• 5. Multiple sclerosis outcomes following a cancer diagnosis in individuals with recorded chemotherapy exposure: a real-world MSBase study. https://pubmed.ncbi.nlm.nih.gov/42543909/
• 6. Risk prediction models for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a systematic review and critical appraisal. https://pubmed.ncbi.nlm.nih.gov/42632423/
• 7. Comparison of postoperative recovery metrics following stereoencephalography and subdural grid electrode implantation in pharmacoresistant epilepsy. https://pubmed.ncbi.nlm.nih.gov/42107918/
• 8. Impact of antithyroid drug duration on radioactive iodine therapy efficacy in Japanese patients with Graves' disease: a propensity score-matched analysis using thyroid weight-based outcomes. https://pubmed.ncbi.nlm.nih.gov/42421503/

Disclaimer: The information provided in this article is for reference purposes only and cannot replace an in-person consultation with a qualified medical specialist. Always consult a doctor for the diagnosis and treatment of diseases.